vs
安进（AMGN）与BJ's Wholesale Club Holdings, Inc.（BJ）财务数据对比。点击上方公司名可切换其他公司
安进的季度营收约是BJ's Wholesale Club Holdings, Inc.的1.8倍（$9.9B vs $5.3B），安进净利率更高（13.5% vs 2.8%，领先10.7%），安进同比增速更快（8.6% vs 4.9%），安进自由现金流更多（$961.0M vs $-13.7M），过去两年安进的营收复合增速更高（15.1% vs -0.1%）
安进是总部位于美国加利福尼亚州千橡市的跨国生物制药企业，公司名称取自最初的全称「应用分子遗传学」的缩写组合，按营收规模排名位列全球生物医药企业第18位，专注于研发、生产及商业化创新生物药物，为全球患者提供优质治疗选择。
BJ's Wholesale Club Holdings是美国区域型会员制仓储连锁商超，总部位于马萨诸塞州马尔伯勒，业务覆盖美国东部地区及俄亥俄、密歇根、肯塔基州路易斯维尔、印第安纳、田纳西、佛罗里达、阿拉巴马等地，主要竞争对手为好市多和山姆会员店。
AMGN vs BJ — 直观对比
营收规模更大
AMGN
是对方的1.8倍
$5.3B
营收增速更快
AMGN
高出3.7%
4.9%
净利率更高
AMGN
高出10.7%
2.8%
自由现金流更多
AMGN
多$974.7M
$-13.7M
两年增速更快
AMGN
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $9.9B | $5.3B |
| 净利润 | $1.3B | $152.1M |
| 毛利率 | 69.8% | 19.0% |
| 营业利润率 | 27.6% | 4.1% |
| 净利率 | 13.5% | 2.8% |
| 营收同比 | 8.6% | 4.9% |
| 净利润同比 | 112.6% | -2.4% |
| 每股收益（稀释后） | $2.45 | $1.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMGNBJ
| Q4 25 | $9.9B | $5.3B | ||
| Q3 25 | $9.6B | $5.4B | ||
| Q2 25 | $9.2B | $5.2B | ||
| Q1 25 | $8.1B | $5.3B | ||
| Q4 24 | $9.1B | $5.1B | ||
| Q3 24 | $8.5B | $5.2B | ||
| Q2 24 | $8.4B | $4.9B | ||
| Q1 24 | $7.4B | $5.4B |
净利润AMGNBJ
| Q4 25 | $1.3B | $152.1M | ||
| Q3 25 | $3.2B | $150.7M | ||
| Q2 25 | $1.4B | $149.8M | ||
| Q1 25 | $1.7B | $122.7M | ||
| Q4 24 | $627.0M | $155.7M | ||
| Q3 24 | $2.8B | $145.0M | ||
| Q2 24 | $746.0M | $111.0M | ||
| Q1 24 | $-113.0M | $145.9M |
毛利率AMGNBJ
| Q4 25 | 69.8% | 19.0% | ||
| Q3 25 | 67.8% | 18.7% | ||
| Q2 25 | 67.2% | 18.8% | ||
| Q1 25 | 63.6% | 18.0% | ||
| Q4 24 | 65.7% | 19.1% | ||
| Q3 24 | 61.1% | 18.4% | ||
| Q2 24 | 61.4% | 18.0% | ||
| Q1 24 | 57.0% | 18.0% |
营业利润率AMGNBJ
| Q4 25 | 27.6% | 4.1% | ||
| Q3 25 | 26.4% | 4.0% | ||
| Q2 25 | 28.9% | 4.0% | ||
| Q1 25 | 14.5% | 3.4% | ||
| Q4 24 | 25.4% | 4.5% | ||
| Q3 24 | 24.1% | 3.9% | ||
| Q2 24 | 22.8% | 3.3% | ||
| Q1 24 | 13.3% | 4.0% |
净利率AMGNBJ
| Q4 25 | 13.5% | 2.8% | ||
| Q3 25 | 33.7% | 2.8% | ||
| Q2 25 | 15.6% | 2.9% | ||
| Q1 25 | 21.2% | 2.3% | ||
| Q4 24 | 6.9% | 3.1% | ||
| Q3 24 | 33.3% | 2.8% | ||
| Q2 24 | 8.9% | 2.3% | ||
| Q1 24 | -1.5% | 2.7% |
每股收益（稀释后）AMGNBJ
| Q4 25 | $2.45 | $1.15 | ||
| Q3 25 | $5.93 | $1.14 | ||
| Q2 25 | $2.65 | $1.13 | ||
| Q1 25 | $3.20 | $0.92 | ||
| Q4 24 | $1.17 | $1.17 | ||
| Q3 24 | $5.22 | $1.08 | ||
| Q2 24 | $1.38 | $0.83 | ||
| Q1 24 | $-0.21 | $1.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.1B | $45.1M |
| 总债务越低越好 | $54.6B | $399.0M |
| 股东权益账面价值 | $8.7B | $2.2B |
| 总资产 | $90.6B | $7.5B |
| 负债/权益比越低杠杆越低 | 6.31× | 0.18× |
8季度趋势，按日历期对齐
现金及短期投资AMGNBJ
| Q4 25 | $9.1B | $45.1M | ||
| Q3 25 | $9.4B | $47.3M | ||
| Q2 25 | $8.0B | $39.5M | ||
| Q1 25 | $8.8B | $28.3M | ||
| Q4 24 | $12.0B | $33.9M | ||
| Q3 24 | $9.0B | $38.1M | ||
| Q2 24 | $9.3B | $35.1M | ||
| Q1 24 | $9.7B | $36.0M |
总债务AMGNBJ
| Q4 25 | $54.6B | $399.0M | ||
| Q3 25 | $54.6B | $399.0M | ||
| Q2 25 | $56.2B | $398.9M | ||
| Q1 25 | $57.4B | $398.8M | ||
| Q4 24 | $60.1B | $398.7M | ||
| Q3 24 | $60.4B | $398.6M | ||
| Q2 24 | $62.6B | $398.5M | ||
| Q1 24 | $64.0B | $398.4M |
股东权益AMGNBJ
| Q4 25 | $8.7B | $2.2B | ||
| Q3 25 | $9.6B | $2.1B | ||
| Q2 25 | $7.4B | $2.0B | ||
| Q1 25 | $6.2B | $1.8B | ||
| Q4 24 | $5.9B | $1.8B | ||
| Q3 24 | $7.5B | $1.7B | ||
| Q2 24 | $5.9B | $1.5B | ||
| Q1 24 | $5.0B | $1.5B |
总资产AMGNBJ
| Q4 25 | $90.6B | $7.5B | ||
| Q3 25 | $90.1B | $7.2B | ||
| Q2 25 | $87.9B | $7.2B | ||
| Q1 25 | $89.4B | $7.1B | ||
| Q4 24 | $91.8B | $7.2B | ||
| Q3 24 | $90.9B | $6.9B | ||
| Q2 24 | $90.9B | $6.8B | ||
| Q1 24 | $93.0B | $6.7B |
负债/权益比AMGNBJ
| Q4 25 | 6.31× | 0.18× | ||
| Q3 25 | 5.67× | 0.19× | ||
| Q2 25 | 7.57× | 0.20× | ||
| Q1 25 | 9.24× | 0.22× | ||
| Q4 24 | 10.23× | 0.23× | ||
| Q3 24 | 8.02× | 0.24× | ||
| Q2 24 | 10.57× | 0.26× | ||
| Q1 24 | 12.75× | 0.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.6B | $181.1M |
| 自由现金流经营现金流 - 资本支出 | $961.0M | $-13.7M |
| 自由现金流率自由现金流/营收 | 9.7% | -0.3% |
| 资本支出强度资本支出/营收 | 6.5% | 3.6% |
| 现金转化率经营现金流/净利润 | 1.20× | 1.19× |
| 过去12个月自由现金流最近4个季度 | $8.1B | $249.6M |
8季度趋势，按日历期对齐
经营现金流AMGNBJ
| Q4 25 | $1.6B | $181.1M | ||
| Q3 25 | $4.7B | $249.9M | ||
| Q2 25 | $2.3B | $208.1M | ||
| Q1 25 | $1.4B | $271.9M | ||
| Q4 24 | $4.8B | $206.8M | ||
| Q3 24 | $3.6B | $221.4M | ||
| Q2 24 | $2.5B | $200.8M | ||
| Q1 24 | $689.0M | $274.4M |
自由现金流AMGNBJ
| Q4 25 | $961.0M | $-13.7M | ||
| Q3 25 | $4.2B | $84.3M | ||
| Q2 25 | $1.9B | $67.6M | ||
| Q1 25 | $980.0M | $111.5M | ||
| Q4 24 | $4.4B | $18.8M | ||
| Q3 24 | $3.3B | $87.5M | ||
| Q2 24 | $2.2B | $95.1M | ||
| Q1 24 | $459.0M | $155.2M |
自由现金流率AMGNBJ
| Q4 25 | 9.7% | -0.3% | ||
| Q3 25 | 44.4% | 1.6% | ||
| Q2 25 | 20.8% | 1.3% | ||
| Q1 25 | 12.0% | 2.1% | ||
| Q4 24 | 48.4% | 0.4% | ||
| Q3 24 | 39.0% | 1.7% | ||
| Q2 24 | 26.5% | 1.9% | ||
| Q1 24 | 6.2% | 2.9% |
资本支出强度AMGNBJ
| Q4 25 | 6.5% | 3.6% | ||
| Q3 25 | 4.6% | 3.1% | ||
| Q2 25 | 4.0% | 2.7% | ||
| Q1 25 | 5.0% | 3.0% | ||
| Q4 24 | 4.1% | 3.7% | ||
| Q3 24 | 3.0% | 2.6% | ||
| Q2 24 | 2.8% | 2.1% | ||
| Q1 24 | 3.1% | 2.2% |
现金转化率AMGNBJ
| Q4 25 | 1.20× | 1.19× | ||
| Q3 25 | 1.46× | 1.66× | ||
| Q2 25 | 1.59× | 1.39× | ||
| Q1 25 | 0.80× | 2.22× | ||
| Q4 24 | 7.61× | 1.33× | ||
| Q3 24 | 1.26× | 1.53× | ||
| Q2 24 | 3.30× | 1.81× | ||
| Q1 24 | — | 1.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMGN
| Products | $9.4B | 95% |
| Xgeva | $291.0M | 3% |
| Vectibix | $163.0M | 2% |
| Aranesp | $115.0M | 1% |
BJ
| Products | $5.4B | 102% |
| Membership | $129.8M | 2% |
